HHS Pandemic Response Plan Could Be Hindered By SEC Regulations
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS' efforts to increase manufacturing capacity to prepare for an influenza pandemic could be affected if manufacturers are unable to record stockpile revenue under Securities & Exchange Commission regulations